Principal Financial Group Inc Liva Nova PLC Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$43.38 - $54.59 $1.79 Million - $2.26 Million	-41,335 Reduced 19.43%	171,402 $9 Million
Q2 2024 Jul 29, 2024	SELL	$51.76 - $64.15 $979,765 - $1.21 Million	-18,929 Reduced 8.17%	212,737 $11.7 Million
Q1 2024 Apr 29, 2024	BUY	$48.6 - $57.12 $305,256 - $358,770	6,281 Added 2.79%	231,666 $13 Million
Q4 2023 Feb 07, 2024	BUY	$43.45 - $53.66 $231,545 - $285,954	5,329 Added 2.42%	225,385 $11.7 Million
Q3 2023 Nov 02, 2023	BUY	$50.12 - $58.87 $265,184 - $311,481	5,291 Added 2.46%	220,056 $11.6 Million
Q2 2023 Aug 07, 2023	SELL	$42.28 - $51.43 $281,119 - $341,958	-6,649 Reduced 3.0%	214,765 $11 Million
Q1 2023 May 09, 2023	BUY	$40.84 - $58.14 $12,088 - $17,209	296 Added 0.13%	221,414 $9.65 Million
Q4 2022 Feb 09, 2023	BUY	$43.88 - $56.16 $175,651 - $224,808	4,003 Added 1.84%	221,118 $12.3 Million
Q3 2022 Nov 09, 2022	BUY	$48.37 - $66.5 $251,717 - $346,066	5,204 Added 2.46%	217,115 $11 Million
Q2 2022 Aug 10, 2022	BUY	$57.25 - $86.63 $1.57 Million - $2.38 Million	27,441 Added 14.88%	211,911 $13.2 Million
Q1 2022 May 09, 2022	SELL	$71.02 - $86.99 $74,784 - $91,600	-1,053 Reduced 0.57%	184,470 $15.1 Million
Q4 2021 Feb 09, 2022	SELL	$76.72 - $92.68 $319,462 - $385,919	-4,164 Reduced 2.2%	185,523 $16.2 Million
Q3 2021 Nov 09, 2021	BUY	$76.02 - $88.62 $1.24 Million - $1.44 Million	16,262 Added 9.38%	189,687 $15 Million
Q2 2021 Aug 10, 2021	BUY	$73.44 - $87.01 $45,679 - $54,120	622 Added 0.36%	173,425 $14.6 Million
Q1 2021 May 10, 2021	BUY	$62.9 - $82.41 $1.39 Million - $1.82 Million	22,128 Added 14.69%	172,803 $12.7 Million
Q4 2020 Feb 08, 2021	BUY	$46.01 - $68.74 $123,996 - $185,254	2,695 Added 1.82%	150,675 $9.98 Million
Q3 2020 Nov 06, 2020	SELL	$41.91 - $57.81 $228,660 - $315,411	-5,456 Reduced 3.56%	147,980 $6.69 Million
Q2 2020 Aug 05, 2020	BUY	$39.87 - $56.9 $69,294 - $98,892	1,738 Added 1.15%	153,436 $7.39 Million
Q1 2020 May 12, 2020	SELL	$34.22 - $76.49 $2.08 Million - $4.65 Million	-60,841 Reduced 28.63%	151,698 $6.87 Million
Q4 2019 Feb 05, 2020	BUY	$68.92 - $85.27 $59,960 - $74,184	870 Added 0.41%	212,539 $16 Million
Q3 2019 Nov 13, 2019	SELL	$71.74 - $86.35 $182,721 - $219,933	-2,547 Reduced 1.19%	211,669 $15.6 Million
Q2 2019 Aug 12, 2019	SELL	$66.45 - $97.36 $262,876 - $385,156	-3,956 Reduced 1.81%	214,216 $15.4 Million
Q1 2019 May 10, 2019	BUY	$86.15 - $100.49 $97,435 - $113,654	1,131 Added 0.52%	218,172 $21.2 Million
Q4 2018 Feb 14, 2019	SELL	$84.14 - $125.42 $420,784 - $627,225	-5,001 Reduced 2.25%	217,041 $19.9 Million
Q3 2018 Nov 14, 2018	BUY	$101.02 - $130.95 $2.58 Million - $3.34 Million	25,505 Added 12.98%	222,042 $27.5 Million
Q2 2018 Aug 13, 2018	BUY	$81.75 - $105.37 $377,031 - $485,966	4,612 Added 2.4%	196,537 $0
Q1 2018 May 14, 2018	BUY	$79.95 - $89.74 $442,283 - $496,441	5,532 Added 2.97%	191,925 $17 Million
Q4 2017 Feb 13, 2018	SELL	$71.8 - $88.21 $22,401 - $27,521	-312 Reduced 0.17%	186,393 $14.9 Million
Q3 2017 Nov 02, 2017	BUY	$60.32 - $70.06 $11.3 Million - $13.1 Million	186,705	186,705 $13.1 Million

Others Institutions Holding LIVN

# of Institutions

262

Shares Held

52.9M

Call Options Held

316K

Put Options Held

127K

Black Rock Inc. New York, NY

6.9M
Shares

$322 Million
0.01% of portfolio
Primecap Management CO Pasadena, CA

5.63M
Shares

$263 Million
0.22% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.96M
Shares

$138 Million
0.08% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

2.09M
Shares

$97.6 Million
0.3% of portfolio
Vanguard Group Inc Valley Forge, PA

2.08M
Shares

$97.3 Million
0.0% of portfolio

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.5B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account